0.9001USD+7.14%Mkt Cap: 195.52M USDP/E: —Last update: 2026-06-01
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap195.52M USD
Enterprise Value117.80M USD
Revenue (TTM)225.00K USD
Gross Profit225.00K USD
Net Income (TTM)-90.60M USD
Revenue/Share0.0010 USD
Last Price0.9001 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees70
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.10
PEG—
EV/EBITDA-1.50
EV/Revenue523.56
P/S838.10
P/B1.53
EPS (TTM)-0.44
EPS (Forward)-0.41
52W Range
0.431024% of range2.350
52W High2.350 USD
52W Low0.4310 USD
Profitability
Gross Margin100.00%
Oper. Margin-8917.78%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-73.50%
ROA-61.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-68.26M USD
CapEx (TTM)618.00K USD
FCF Margin-18621.44%
FCF Yield-21.43%
Net Debt-70.77M USD
Net Debt/EBITDA0.90
Balance Sheet
Debt/Equity0.09
Current Ratio5.75
Quick Ratio5.45
Book Value/Sh0.5690 USD
Cash/Share0.3730 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)4.000 USD
Target Range2.000 USD – 8.000 USD
# Analysts6
Ownership
Shares Out.217.00M
Float216.08M
Insiders0.47%
Institutions48.38%
Short Interest
Short Ratio5.9d
Short % Float17.23%
Short % Out.13.25%
Shares Short28.75M
Short (prev mo.)26.08M
Technical
SMA 500.7633 (+17.9%)
SMA 2001.033 (-12.9%)
Beta2.77
S&P 52W Chg27.70%
Avg Vol (30d)4.44M
Avg Vol (10d)3.53M
Technical Indicators
RSI (14)54.3
MACD0.0099
MACD Signal0.0193
MACD Hist.-0.0094
BB Upper1.018 USD
BB Middle0.8395 USD
BB Lower0.6604 USD
BB Width42.66%
ATR (14)0.0697 USD
Vol Ratio (20d)0.69x